1758
M. Morita et al. / Tetrahedron 64 (2008) 1753e1758
2.38 (s, 3H), 5.64 (d, 1H, J¼8.6 Hz), 5.91 (dd, 1H, J¼7.8,
10.8 Hz), 6.22 (t, 1H, J¼10.3 Hz), 7.07 (d, 1H, J¼7.6 Hz),
9.74 (br, 1H). 13C NMR (CDCl3): d¼ꢁ1.66, 22.69, 26.96,
120.61, 120.68, 124.54, 125.81, 134.77, 135.42, 139.96, 148.14,
165.61. EIMS: m/z¼277 (Mþ). HRMS (Mþ): calcd for
C14H19NOSSi: 277.0957; found: 277.0956.
References and notes
1. For reviews on TMSCHN2, see: (a) Hodnett, N. S. Synlett 2003, 2095e
2096; (b) Shioiri, T.; Aoyama, T. Science of Synthesis; Fleming, I., Ed.;
Georg Thieme: Stuttgart, 2002; Vol. 4, p 569; (c) Shioiri, T.; Aoyama,
T. J. Synth. Org. Chem., Jpn. 1996, 54, 918e928; (d) Shioiri, T.; Aoyama,
T. Advances in the Use of Synthons in Organic Chemistry; Dondoni, A.,
Ed.; JAI: London, 1993; Vol. 1, p 51.
2. For our recent application of TMSCHN2, see: (a) Hari, Y.; Kanie, T.;
Aoyama, T. Tetrahedron Lett. 2006, 47, 1137e1139; (b) Hari, Y.; Kanie,
T.; Miyagi, T.; Aoyama, T. Synthesis 2006, 1249e1252; (c) Hari, Y.;
Tsuchida, S.; Aoyama, T. Tetrahedron Lett. 2006, 47, 1977e1980; (d)
Tsuchida, S.; Hari, Y.; Aoyama, T. Heterocycles 2005, 65, 2667e2674;
(e)Miyagi, T.;Hari, Y.; Aoyama, T. TetrahedronLett. 2004, 45, 6303e6305.
3. (a) Hari, Y.; Iguchi, T.; Aoyama, T. Synthesis 2004, 1359e1362; (b) Hari,
Y.; Iguchi, T.; Aoyama, T. Synthesis 2005, 2147e2150.
4. The synthesis of thiazolones from diazo compounds and thiobenzoyl iso-
cyanate was reported. See: (a) Tsuge, O.; Shinaki, I.; Koga, M. Bull.
Chem. Soc. Jpn. 1972, 45, 3657e3660; (b) Goerdeler, J.; Schimpf, R.
Chem. Ber. 1973, 106, 1496e1500.
4.5.5. A mixture of 5-methyl-3-[(trimethylsilyl)methylthio]-
cyclohepta[c]pyrrol-1-ol (5e) and 7-methyl-3-[(trimethyl-
silyl)methylthio]cyclohepta[c]pyrrol-1-ol
Yield 54% (major/minor¼ca. 2.5:1). Brown amorphous. IR
(Nujol): n¼1681, 1634 cmꢁ1
.
1H NMR (CDCl3): major:
d¼0.13 (s, 9H), 1.91 (s, 3H), 2.09 (s, 2H), 5.89 (dd, 1H, J¼
7.8, 11.9 Hz), 6.05e6.14 (m, 1H), 6.67e6.75 (m, 1H), 6.90
(d, 1H, J¼1.1 Hz), 9.32 (br, 1H). Minor: d¼0.12 (s, 3H),
1.96 (s, 3H), 2.08 (s, 2H), 5.60 (dd, 1H, J¼8.4, 11.3 Hz),
6.05e6.14 (m, 1H), 6.67e6.75 (m, 1H), 6.88 (d, 1H, J¼
1.1 Hz), 9.32 (br, 1H). EIMS: m/z¼277 (Mþ). HRMS (Mþ):
calcd for C14H19NOSSi: 277.0957; found: 277.0955.
5. Buchner, E. Chem. Ber. 1896, 29, 106e109.
6. (a) Goerdeler, J.; Weiss, R. Chem. Ber. 1967, 100, 1627e1632; (b) Weiss,
R. Chem. Ber. 1967, 100, 685e689; (c) Tsuge, O.; Kanemasa, S.; Tashiro,
M. Tetrahedron 1968, 24, 5205e5214.
4.5.6. 5,7-Dimethyl-3-[(trimethylsilyl)methylthio]cyclohepta-
[c]pyrrol-1-ol (5f)
7. The diazoketone 4a seemed to be formed by protodesilylation of 3a with
water during the purification by silica gel column chromatography.
8. For a review on the S-ylide formation, see: Padwa, A.; Hornbuckle, S. F.
Chem. Rev. 1991, 91, 263e309.
Yield 12%. Black amorphous. IR (Nujol): n¼3221,
1
1715 cmꢁ1. H NMR (CDCl3): d¼0.12 (s, 9H), 1.91 (s, 3H),
9. (a) Walter, W.; Meese, C. O. Chem. Ber. 1976, 109, 922e946; (b) Walter,
W.; Meese, C. O. Chem. Ber. 1977, 110, 2463e2479.
1.98 (s, 3H), 2.09 (s, 2H), 6.03 (s, 1H), 6.64 (s, 1H), 6.90 (s,
1H), 9.45 (s, 1H). 13C NMR (CDCl3): d¼ꢁ1.70, 21.06, 26.08,
26.80, 118.25, 121.08, 129.45, 131.01, 134.46, 134.77, 137.05,
140.16, 165.73. EIMS: m/z¼291 (Mþ). HRMS (Mþ): calcd for
C15H21NOSSi: 291.1113; found: 291.1123.
10. (a) CuCl:Constantino,A.;Linstrumelle,G.;Julia,S.Bull. Soc. Chim. Fr. 1970,
907e912; Scott, L. T.; Minton, M. A.; Kirms, M. A. J. Am. Chem. Soc. 1980,
102, 6311e6314; (b) Cu(hfacac)2: Pusino, A.; Saba, A. Tetrahedron 1986, 42,
4319e4324; (c) Cu(OTf)2: Yadav, J. S.; Reddy, B. V. S.; Gupta, M. K.;
Prabhakar, A.; Jagadeesh, B. Chem. Commun. 2004, 2124e2125.
11. The low yields were presumably due to decomposition of the resulting 5d
and 5f during the purification by silica gel column chromatography be-
cause of their relative lability.
4.5.7. 7-Methoxy-1-[(trimethylsilyl)methylthio]isoquinolin-
3-ol (7g)
Yield 11%. A yellow oil. IR (neat): n¼2956, 1636 cmꢁ1. 1H
NMR (CDCl3): d¼0.18 (s, 9H), 2.47 (s, 2H), 3.93 (s, 3H), 6.47
(s, 1H), 7.22 (dd, 1H, J¼2.2, 8.9 Hz), 7.33 (d, 1H, J¼2.2 Hz),
7.52 (d, 1H, J¼8.9 Hz). 13C NMR (CDCl3): d¼ꢁ1.36, 15.19,
55.52, 96.24, 102.38, 123.74, 124.42, 127.47, 134.73, 155.95,
156.48, 157.57. EIMS: m/z¼293 (Mþ). HRMS (Mþ): calcd for
C14H19NO2SSi: 293.0906; found: 293.0909.
12. (a) Marguire, A. R.; O’Leary, P.; Harrington, F.; Lawrence, S. E.; Blake,
A. J. J. Org. Chem. 2001, 66, 7166e7177; (b) Kennedy, M.; Mckervey,
M. A.; Maguire, A. R.; Tuladhar, S. M.; Twohig, M. F. J. Chem. Soc.,
Perkin Trans. 1 1990, 1047e1054.
13. Many researches about drug discovery of azaazulenes were reported. For
example: (a) 1-Azaazulenes:Chem. Pharm. Bull. 1994, 42, 2491e2499;
(b) 1,3-Diaazaazulenes: Satake, N.; Zhou, Q.; Kosakai, K.; Nimura, M.;
Shibata, S. Eur. J. Pharmacol. 1994, 251, 1e7; (c) 1,2-Diazaazulenes:
Imafuku, K.; Aradono, K.; Uono, T.; Ogawa, K.; Matsushita, Y. Chem.
Pharm. Bull. 1992, 40, 1606e1609.
4.5.8. 5,7-Dimethoxy-1-[(trimethylsilyl)methylthio]-
isoquinolin-3-ol (7h)
14. Many studies about synthesis of biologically active azulenes were re-
ported. For example: (a) Fujio, K.; Kobayashi, H.; Ozeki, S.; Fujimori,
K. Chem. Lett. 2006, 35, 1272e1273; (b) Rekka, E.; Chrysselis, M.;
Siskou, I.; Kourounakis, A. Chem. Pharm. Bull. 2002, 50, 904e907; (c)
Noguchi, K.; Kase, J.; Saitoh, M.; Masumiya, H.; Saitoh, M.; Nakazawa,
T.; Tanaka, Y.; Tanaka, H.; Hashimoto, K.; Shigenobu, K. Pharmacology
2002, 64, 36e42; (d) Hong, B.-C.; Jiang, Y.-F.; Kumar, E. S. Bioorg. Med.
Chem. Lett. 2001, 11, 1981e1984; (e) Yokota, M.; Uchibori, S.; Hayashi,
H.; Koyama, R.; Kosakai, K.; Wakabayashi, S.; Tomiyama, T. Bioorg.
Med. Chem. 1996, 4, 575e591; (f) Asato, A. E.; Peng, A.; Hossain,
M. Z.; Mirzadegan, T.; Bertram, J. S. J. Med. Chem. 1993, 36, 3137e
3147; (g) Tomiyama, T.; Yokota, M.; Wakabayashi, S.; Kosakai, K.; Yana-
gisawa, T. J. Med. Chem. 1993, 36, 791e800.
Yield 44%. A yellow solid. Mp 103e106 ꢀC (EtOAc). IR
1
(Nujol): n¼1641 cmꢁ1. H NMR (CDCl3): d¼0.19 (s, 9H),
2.46 (s, 2H), 3.83 (s, 3Hꢂ2), 6.56 (d, 1H, J¼1.6 Hz), 6.89
(d, 1H, J¼1.6 Hz), 6.98 (s, 1H). 13C NMR (CDCl3): d¼
ꢁ1.46, 15.37, 55.49, 55.63, 92.43, 93.92, 101.40, 123.56,
128.60, 154.98, 156.22, 156.55, 156.91. EIMS: m/z¼323 (Mþ).
HRMS (Mþ): calcd for C15H21NO3SSi: 323.1012; found:
323.1014.
15. (a) Kreher, R.; Vogt, G.; Schultz, M. L. Angew. Chem., Int. Ed. Engl.
1975, 14, 821; (b) Jones, R. A.; Singh, S. Heterocycles 1976, 4, 969e
972; (c) Seitz, G.; The, H. S. Synthesis 1984, 119e121.
16. Goerdeler, J.; Schenk, H. Chem. Ber. 1965, 98, 2954e2965.
17. Kehrbach, W.; Mlinaric, M.; Ziegler, D.; Brueckner, R.; Bielenberg, W.
U.S. Patent 5,547,967, 1996.
Acknowledgements
This work was financially supported by a Grant-in-Aid for
Scientific Research (KAKENHI). M.M. was financially sup-
ported by Pfizer Japan Inc.